|
Wnt Antagonist Gene Hypermethylation in Circulating DNA: Cancer Biomarker
|
ZIA BC 011050
|
$55,899
|
$33,539
|
Rubin, Jeffrey
|
CCR (NCI)
|
|
University of Colorado Southwest Oncology Group
|
5U10CA042777-22
|
$83,653
|
$837
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$240,008
|
$48,002
|
Fowler, Daniel
|
CCR (NCI)
|
|
U10 Ful Member Application Affiliated with SWOG
|
5U10CA105409-06
|
$215,937
|
$2,159
|
HERBST, ROY
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Translational Surgical Pathology
|
ZIE SC 000853
|
$287,498
|
$172,499
|
Merino, Maria
|
CCR (NCI)
|
|
Tissue Array Research Program
|
ZIC BC 010923
|
$787,346
|
$118,102
|
Hewitt, Stephen
|
CCR (NCI)
|
|
The Role of Fgf Signaling in Vertebrate Development
|
ZIA BC 010338
|
$301,445
|
$60,289
|
Lewandoski, Mark
|
CCR (NCI)
|
|
Technical Development of Molecular Profiling Technologies
|
ZIC BC 011041
|
$310,828
|
$310,828
|
Edelman, Daniel
|
CCR (NCI)
|
|
Study of tumor pathogenesis and development of therapies for AIDS-malignancies
|
ZIA BC 010885
|
$507,326
|
$50,733
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Study of Hereditary Renal and Other Familial Syndromes
|
ZIA BC 010696
|
$287,498
|
$229,998
|
Merino, Maria
|
CCR (NCI)
|
|
Southwest Oncology Group/ University of California,
|
5U10CA046441-22
|
$348,516
|
$3,485
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
Southwest Oncology Group Statistical Center
|
5U10CA038926-24
|
$4,746,162
|
$47,462
|
CROWLEY, JOHN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
SOUTHWEST ONCOLOGY GROUP - OPERATIONS OFFICE
|
5U10CA032102-30
|
$9,379,270
|
$93,793
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group
|
5U10CA004919-50
|
$195,727
|
$1,957
|
BUDD, G
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Southwest Oncology Group
|
5U10CA046282-22
|
$389,625
|
$3,896
|
STIFF, PATRICK
|
LOYOLA UNIVERSITY CHICAGO
|
|
Southwest Oncology Group
|
5U10CA020319-33
|
$347,108
|
$3,471
|
RIVKIN, SAUL
|
SWEDISH MEDICAL CENTER, FIRST HILL
|
|
SOUTHWEST ONCOLOGY GROUP
|
5U10CA013612-36
|
$271,162
|
$2,712
|
MILLER, THOMAS
|
UNIVERSITY OF ARIZONA
|
|
Southwest Oncology Group
|
5U10CA027057-30
|
$267,015
|
$2,670
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group
|
5U10CA011083-42
|
$359,154
|
$3,592
|
FISHER, RICHARD
|
UNIVERSITY OF ROCHESTER
|
|
Southwest Oncology Group
|
5U10CA058882-17
|
$262,855
|
$2,629
|
LENZ, HEINZ
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Southwest Oncology Group
|
5U10CA014028-36
|
$221,046
|
$2,210
|
FLAHERTY, LAWRENCE
|
WAYNE STATE UNIVERSITY
|
|
Signal Transduction Events and the Regulation of Cell Growth
|
ZIC SC 006743
|
$543,819
|
$135,955
|
Trepel, Jane
|
CCR (NCI)
|
|
Serum Antibody Profiling with a Carbohydrate Microarray
|
ZIA BC 011055
|
$258,885
|
$51,777
|
Gildersleeve, Jeffrey
|
CCR (NCI)
|
|
Role of Trk Receptors in the Development and Function of Non-neuronal Structures
|
ZIA BC 010391
|
$428,531
|
$42,853
|
Tessarollo, Lino
|
CCR (NCI)
|
|
Role of HSP90 Family Chaperone Proteins in Cellular Signal Transduction
|
ZIA SC 010074
|
$479,457
|
$239,728
|
Neckers, Leonard
|
CCR (NCI)
|
|
Role of FH loss in development of HLRCC heriditary kidney cancer
|
ZIA BC 010683
|
$239,728
|
$239,728
|
Neckers, Leonard
|
CCR (NCI)
|
|
Research Nursing
|
ZID BC 010950
|
$3,823,571
|
$191,179
|
Giaccone, Giuseppe
|
CCR (NCI)
|
|
R-spondins, Secreted Frizzled-Related Proteins and the Regulation of Wnt Signalin
|
ZIA BC 010251
|
$419,244
|
$125,773
|
Rubin, Jeffrey
|
CCR (NCI)
|
|
Proteomic Analysis of Renal Tumors
|
ZIA SC 009392
|
$191,665
|
$191,665
|
Merino, Maria
|
CCR (NCI)
|
|
Promoting tumor cell apoptosis by death ligands
|
ZIA BC 011056
|
$376,234
|
$237,027
|
Sayers, Thomas
|
CCR (NCI)
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$175,907
|
$35,181
|
Bottaro, Donald
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: VHL Gene and Fumarate Hydratase Gene
|
ZIA BC 011038
|
$1,027,647
|
$770,735
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Therapeutics of Kidney Cancer: MET Gene and BHD Gene
|
ZIA BC 011043
|
$1,027,647
|
$1,017,371
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Molecular Profiling of Clinical Specimens
|
ZIC BC 011040
|
$1,243,310
|
$683,821
|
Edelman, Daniel
|
CCR (NCI)
|
|
Molecular Modeling of the Human P-glycoprotein Transporter Protein
|
ZIC BC 011075
|
$47,375
|
$23,687
|
Durell, Stewart
|
CCR (NCI)
|
|
Molecular Genetic Study of Stem Cells, Cancer Stem Cells, and Stem Cell Aging
|
ZIA BC 010738
|
$1,042,212
|
$416,885
|
Hou, Steven
|
CCR (NCI)
|
|
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance
|
ZIA BC 010625
|
$490,729
|
$196,292
|
Fojo, Antonio
|
CCR (NCI)
|
|
Metabolic Mechanisms for Programmed Cell Death
|
ZIA BC 010743
|
$422,329
|
$168,932
|
Phang, James
|
CCR (NCI)
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,416,561
|
$441,656
|
Fojo, Antonio
|
CCR (NCI)
|
|
Medical Director's Office
|
ZID BC 010951
|
$1,706,951
|
$17,070
|
Giaccone, Giuseppe
|
CCR (NCI)
|
|
Mechanisms of non-classical multidrug resistance in cancer
|
ZIA BC 010830
|
$637,360
|
$31,868
|
Gottesman, Michael
|
CCR (NCI)
|
|
Mechanisms of Leukocyte Migration Following Cytokine Administration to Mice
|
ZIA BC 009322
|
$278,192
|
$27,819
|
Wiltrout, Robert
|
CCR (NCI)
|
|
Mechanisms of Inorganic Carcinogenesis
|
ZIA BC 005488
|
$1,200,404
|
$240,081
|
Waalkes, Michael
|
CCR (NCI)
|
|
Mechanisms of Immune-mediated Tumor Cell Destruction
|
ZIA BC 010012
|
$250,823
|
$150,494
|
Sayers, Thomas
|
CCR (NCI)
|
|
Investigation of the ABC Half-Transporter ABCG2
|
ZIA BC 010622
|
$382,659
|
$76,532
|
Bates, Susan
|
CCR (NCI)
|
|
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
|
ZIB BC 010906
|
$1,316,844
|
$658,422
|
Waldmann, Thomas
|
CCR (NCI)
|
|
Inhibitors of Tyrosine Kinase-Dependent Signalling as Anti-Cancer Agents
|
ZIA BC 006198
|
$701,769
|
$526,326
|
Burke, Terrence
|
CCR (NCI)
|
|
Infections, immunity, and inflammation in cancer
|
ZIA CP010150-10401
|
$12,309
|
$12,309
|
A Engels, Eric
|
DCEG (NCI)
|
|
Immunophysiological Mechanisms in the Biological Therapy of Cancer
|
ZIA BC 009262
|
$333,831
|
$166,915
|
Wiltrout, Robert
|
CCR (NCI)
|
|
Identification of Novel Mutations In Pediatric Cancers
|
ZIA BC 010998
|
$726,889
|
$36,344
|
Khan, Javed
|
CCR (NCI)
|
Total relevant funding to Urinary System for this search: $15,280,944
|